Implementing Brief Tobacco Cessation Interventions in Community Pharmacies: An Application of Rogers' Diffusion of Innovations Theory.

Katy Ellis Hilts, Robin L Corelli, Alexander V Prokhorov, Susan M Zbikowski, Alan J Zillich, Karen Suchanek Hudmon
Author Information
  1. Katy Ellis Hilts: Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA. ORCID
  2. Robin L Corelli: Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA 94117, USA.
  3. Alexander V Prokhorov: MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
  4. Susan M Zbikowski: inZights Consulting, LLC, Seattle, WA 98115, USA.
  5. Alan J Zillich: Department of Pharmacy Practice, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA. ORCID
  6. Karen Suchanek Hudmon: Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA 94117, USA. ORCID

Abstract

Pharmacists, as highly accessible members of the healthcare team, have considerable potential to address tobacco use among patients. However, while published data suggest that pharmacists are effective in helping patients quit, barriers exist to routine implementation of cessation services in community pharmacy settings. Within the context of a randomized trial (n = 64 pharmacies), surveys were administered over a period of 6 months to assess pharmacists' perceptions of factors associated with the implementation of "Ask-Advise-Refer", a brief intervention approach that facilitates patient referrals to the tobacco quitline. Study measures, grounded in Rogers' Diffusion of Innovations Theory, assessed pharmacists' perceptions of implementation facilitators and barriers, perceptions of intervention materials provided, and perceived efforts and personal success in implementing Ask-Advise-Refer at 6-months follow-up. Findings indicate that while the brief intervention approach was not difficult to understand or implement, integration into normal workflows presents greater challenges and is associated with overall confidence and implementation success. Lack of time was the most significant barrier to routine implementation. Most (90.6%) believed that community pharmacies should be active in promoting tobacco quitlines. Study results can inform future development of systems-based approaches that lead to broad-scale adoption of brief interventions, including but not limited to tobacco cessation, in pharmacy settings.

Keywords

References

  1. J Am Pharm Assoc (2003). 2014 Jan-Feb;54(1):42-4 [PMID: 24407740]
  2. PLoS One. 2017 Aug 16;12(8):e0183172 [PMID: 28813473]
  3. J Clin Pharm Ther. 2014 Jun;39(3):240-7 [PMID: 24749899]
  4. Patient Educ Couns. 2006 Apr;61(1):152-60 [PMID: 16533683]
  5. Cochrane Database Syst Rev. 2019 Oct 31;2019(10): [PMID: 31684695]
  6. Prev Med. 2005 Jun;40(6):888-95 [PMID: 15850892]
  7. J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):507-14 [PMID: 22825231]
  8. BMC Med. 2016 Dec 16;14(1):209 [PMID: 27978837]
  9. Nicotine Tob Res. 2011 Feb;13(2):135-45 [PMID: 21196451]
  10. Ann Pharmacother. 2010 Sep;44(9):1395-402 [PMID: 20628045]
  11. J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):9-16 [PMID: 20097634]
  12. J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):387-394 [PMID: 29779983]
  13. Arch Intern Med. 2010 Oct 11;170(18):1640-6 [PMID: 20937922]
  14. Int J Pharm Pract. 2009 Aug;17(4):221-9 [PMID: 20161528]
  15. Arch Intern Med. 2010 Oct 11;170(18):1646-7 [PMID: 20937923]
  16. J Emerg Nurs. 2018 May;44(3):242-248 [PMID: 28864084]
  17. Am J Pharm Educ. 2013 Jun 12;77(5):93 [PMID: 23788804]
  18. Res Social Adm Pharm. 2013 Jul-Aug;9(4):396-404 [PMID: 22841641]
  19. Pharmacotherapy. 2003 May;23(5):666-73 [PMID: 12741442]
  20. J Contin Educ Health Prof. 2011 Fall;31 Suppl 1:S60-6 [PMID: 22190102]
  21. Health Technol Assess. 2015 Nov;19(95):1-156 [PMID: 26565129]
  22. Pharmacotherapy. 2007 Jul;27(7):1040-51 [PMID: 17594210]
  23. Nicotine Tob Res. 2018 Nov 15;20(12):1418-1426 [PMID: 29059419]
  24. Am J Pharm Educ. 2007 Dec 15;71(6):109 [PMID: 19503693]
  25. Res Social Adm Pharm. 2017 Sep - Oct;13(5):889-891 [PMID: 28619650]
  26. MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464 [PMID: 28056007]
  27. J Am Pharm Assoc (2003). 2018 May - Jun;58(3):253-257 [PMID: 29426612]
  28. Res Social Adm Pharm. 2013 Jan-Feb;9(1):27-36 [PMID: 22554394]
  29. Am J Med Qual. 2015 Mar-Apr;30(2):135-40 [PMID: 24500644]
  30. J Subst Abuse Treat. 2019 Apr;99:163-170 [PMID: 30797390]
  31. Res Social Adm Pharm. 2022 Jul;18(7):3158-3163 [PMID: 34544660]

Grants

  1. R01 CA 129312/NCI NIH HHS
  2. R01 CA129312/NCI NIH HHS
  3. T32 CA 117865/NCI NIH HHS
  4. T32 CA117865/NCI NIH HHS
  5. R25 CA236637/NCI NIH HHS

Word Cloud

Created with Highcharts 10.0.0tobaccoimplementationcessationbriefinterventioncommunitypharmacyperceptionspatientsbarriersroutinesettingspharmaciespharmacists'associatedapproachquitlineStudyRogers'DiffusionInnovationsTheorysuccesssmokingPharmacistshighlyaccessiblemembershealthcareteamconsiderablepotentialaddressuseamongHoweverpublisheddatasuggestpharmacistseffectivehelpingquitexistservicesWithincontextrandomizedtrialn=64surveysadministeredperiod6monthsassessfactors"Ask-Advise-Refer"facilitatespatientreferralsmeasuresgroundedassessedfacilitatorsmaterialsprovidedperceivedeffortspersonalimplementingAsk-Advise-Refer6-monthsfollow-upFindingsindicatedifficultunderstandimplementintegrationnormalworkflowspresentsgreaterchallengesoverallconfidenceLacktimesignificantbarrier906%believedactivepromotingquitlinesresultscaninformfuturedevelopmentsystems-basedapproachesleadbroad-scaleadoptioninterventionsincludinglimitedImplementingBriefTobaccoCessationInterventionsCommunityPharmacies:Applicationpharmacist

Similar Articles

Cited By